Worth Venture Partners’s Merck MRK Stock Holding History

Worth Venture Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,900	Closed	-$1.37M	–	183
2023 Q1	$1.37M	Buy	+12,900	New	+$1.39M	0.67%	42

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Worth Venture Partners's MRK Position: Q2 2023 in Review

Worth Venture Partners sold out of Merck (MRK) in Q2 2023, closing a stake of 12,900 shares — an estimated $1.37M sold.

Worth Venture Partners first reported a position in MRK in Q1 2023 and held it in 1 quarter. The position peaked at $1.37M in Q1 2023. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

Worth Venture Partners reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
Worth Venture Partners sold 12,900 Merck shares in Q2 2023, an estimated $1.37M.
Worth Venture Partners first reported a position in Merck in Q1 2023 and held it in 1 quarter.
Worth Venture Partners's Merck position peaked at $1.37M in Q1 2023.
3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Worth Venture Partners's 13F filing for Q2 2023, filed 14 Aug 2023.